The Fortin Drug Discovery Laboratory is working to discover small molecules to treat protein-folding, neuropathologic, and neurotoxicologic disorders. Current investigations include therapeutic strategies for neurodegenerative diseases and type 2 diabetes, neurotoxicity and dysfunction in basal ganglia pathways, and diagnostic investigation of protein-folding disorders.
Thompson TL, Rashid AM, Isa NBM, Kos NS, Fortin JS. Development of a New Class of Inhibitors of Amyloid-β Aggregation. Society of Toxicologic Pathology (STP), Raleigh, June 22-27, 2019.